Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ABLLL NASDAQ:AFJKR NYSE:ASGI NASDAQ:CGABL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028$25.46$25.63$20.52▼$26.36N/AN/A9,052 shsN/AAFJKRAimei Health Technology$0.27-3.9%$0.28$0.24▼$0.49N/AN/A28,631 shs5,501 shsASGIAbrdn Global Infrastructure Income Fund$22.72-0.4%$23.61$19.60▼$25.95N/AN/A201,949 shs109,497 shsCGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061$16.15$17.05$16.10▼$18.80N/AN/A26,555 shs19,922 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 20280.00%-0.20%-2.00%-2.23%+11.42%AFJKRAimei Health Technology+12.75%+12.30%-3.74%-25.33%+4.81%ASGIAbrdn Global Infrastructure Income Fund+1.56%-5.47%-5.19%-2.44%+14.90%CGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061-0.12%-3.00%-4.61%-7.98%-4.89%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028$25.46$25.63$20.52▼$26.36N/AN/A9,052 shsN/AAFJKRAimei Health Technology$0.27-3.9%$0.28$0.24▼$0.49N/AN/A28,631 shs5,501 shsASGIAbrdn Global Infrastructure Income Fund$22.72-0.4%$23.61$19.60▼$25.95N/AN/A201,949 shs109,497 shsCGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061$16.15$17.05$16.10▼$18.80N/AN/A26,555 shs19,922 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 20280.00%-0.20%-2.00%-2.23%+11.42%AFJKRAimei Health Technology+12.75%+12.30%-3.74%-25.33%+4.81%ASGIAbrdn Global Infrastructure Income Fund+1.56%-5.47%-5.19%-2.44%+14.90%CGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061-0.12%-3.00%-4.61%-7.98%-4.89%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 0.00N/AN/AN/AAFJKRAimei Health Technology 0.00N/AN/AN/AASGIAbrdn Global Infrastructure Income Fund 0.00N/AN/AN/ACGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028$250.49MN/AN/AN/AN/AN/AAFJKRAimei Health TechnologyN/AN/AN/AN/AN/AN/AASGIAbrdn Global Infrastructure Income Fund$85.30MN/AN/AN/AN/AN/ACGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061N/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028N/AN/AN/AN/AN/AN/AN/AN/AN/AAFJKRAimei Health TechnologyN/AN/AN/AN/AN/AN/AN/AN/AN/AASGIAbrdn Global Infrastructure Income FundN/AN/AN/AN/AN/AN/AN/AN/AN/ACGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061N/AN/AN/AN/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028N/AN/AN/AN/AN/AAFJKRAimei Health TechnologyN/AN/AN/AN/AN/AASGIAbrdn Global Infrastructure Income Fund$2.5911.40%N/AN/AN/ACGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061N/AN/AN/AN/AN/ALatest CGABL, ABLLL, ASGI, and AFJKR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date1/1/2100CGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061quarterly$0.28916.63%7/31/20268/1/20268/15/20265/11/2026ASGIAbrdn Global Infrastructure Income Fundmonthly$0.2311.52%5/21/20265/21/20265/29/20261/1/2100CGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061quarterly$0.28916.73%5/1/20265/1/20265/15/20264/10/2026ASGIAbrdn Global Infrastructure Income Fundmonthly$0.2311.65%4/22/20264/22/20264/30/20263/10/2026ASGIAbrdn Global Infrastructure Income Fundmonthly$0.2312.69%3/24/20263/24/20263/31/20261/1/2100CGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061quarterly$0.28916.66%1/30/20262/1/20262/15/20261/1/2100CGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061quarterly$0.28916.53%10/31/202511/1/202511/15/20251/1/2100ABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028quarterly$0.61729.8%11/13/202511/13/202511/14/20251/1/2100ABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028quarterly$0.61729.9%8/14/20258/14/20258/15/20251/1/2100CGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061Quarterly$0.28916.79%8/1/20258/1/20258/15/20251/1/2100CGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061quarterly$0.28915.9%5/1/20255/1/20255/15/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028N/AAFJKRAimei Health TechnologyN/AASGIAbrdn Global Infrastructure Income FundN/ACGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061N/AInsider OwnershipCompanyInsider OwnershipABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028N/AAFJKRAimei Health TechnologyN/AASGIAbrdn Global Infrastructure Income FundN/ACGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061N/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028N/AN/AN/AN/AAFJKRAimei Health TechnologyN/AN/AN/AN/AASGIAbrdn Global Infrastructure Income FundN/AN/AN/ANot OptionableCGABLCarlyle Group Inc. 4.625% Subordinated Notes due 2061686N/AN/ANot OptionableCGABL, ABLLL, ASGI, and AFJKR HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCGABL, ABLLL, ASGI, and AFJKR Company DescriptionsAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 NASDAQ:ABLLL$25.46 0.00 (0.00%) As of 06/4/2026Aimei Health Technology NASDAQ:AFJKR$0.27 -0.01 (-3.89%) As of 11:44 AM Eastern This is a fair market value price provided by Massive. Learn more.Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.Abrdn Global Infrastructure Income Fund NYSE:ASGI$22.72 -0.09 (-0.39%) Closing price 03:59 PM EasternExtended Trading$22.71 -0.01 (-0.04%) As of 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Aberdeen Standard Global Infrastructure Income Fund seeks to provide a high level of total return with an emphasis on current income by investing in assets that provide necessary services to society. The Fund seeks to achieve its investment objective by investing in a portfolio of income-producing public and private infrastructure equity investments from around the world.Carlyle Group Inc. 4.625% Subordinated Notes due 2061 NASDAQ:CGABL$16.15 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$16.17 +0.02 (+0.12%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders. the mission of the company is to exploit advances over the past decade in the understanding of glutamate mechanisms involved in a variety of diseases. the company's first drug candidate is being developed for orphan neurological disorders as well as treatment-resistant anxiety and depression. biohaven has assembled a team of experts who have extensive experience in the development of therapeutic agents in this area and also comprise the originators at yale university who discovered the therapeutic potential of glutamate modulation in anxiety and depression. team members have designed and executed successful development programs t More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below Five Below Down 12% Post Earnings—Is the Selloff Overdone? Buy the Dip? Broadcom's AI Moat Is Wider Than Ever The Market Has Ollie’s Bargain Outlet Completely Wrong Broadcom's Whiplash: Shares Tank After Pre-Earnings Surge Navitas: NVIDIA’s AI Power Broker? Macy's Delivers Strong Q1, Raises Outlook, but Wall Street Remains Cautious NVIDIA's New Power Play: Why Fluence Is Surging Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
